Roche later made changes to the trial design, although the company said overall results support further testing.

GeneDx Holdings stock has surged over 3,000% in the past year with promising earnings and market potential, but growth may be ...

Roche revealed early-stage data for a new Alzheimer’s program on Wednesday as it seeks to jump back into a field littered ...

In other developments, Bavarian Nordic announced the launch of a clinical trial of its vaccine in younger children and the ...

SWANA aims to be a “convener and curator” of EPR stakeholder conversations, especially policies that integrate existing recycling systems and make the industry safer.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Roche Holding AG (RHHVF – Research Report) and Pfizer (PFE – ...

Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the mid-stage study has been tied to one death. | Early data suggest ...

Polling shows the presidential election at a near dead heat. In New Hampshire, that jump ball scenario also applies to the governor’s race, which means the outcomes in both contests could hinge on ...

An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...

Biogen now expects annual adjusted profit of between $16.10 per share and $16.60 per share, compared with its previous ...

The Annapolis City Council wants to study marine residential vessels, including houseboats, and their potential impact on businesses and city services. The request for more information is included ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...